IGC

IGC Pharma, Inc.

NYSE· Pharmaceutical Preparations· Inc. MD· CIK 0001326205 Biotech & Drug Discovery

$0.2500 +0.00 (+0.00%)

Oct 23 4:00 PM ET · prev $0.2500

Market cap

$25.6M

Nano cap

Consensus

Buy

80% Buy or better · 5 analysts

Median target

🔒 Subscribers only

1 year

−39.0%

from $0.4100 · Oct 24

30 days

−10.7%

from $0.2800

52-week range

$0.2400–0.4200

−40% from high · low Jul 29

Avg volume 20D

617.1K

Oct 5 spike 1.77M

Short interest

931.5K

≈0.9% of shares · −13.2%

Days to cover

1.4

at average volume

Insider net

no open-market trades · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read MIXED 2 reports · 90 days

Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score

Avg score

·High conf. 1/2 ·Next Earnings date, Nov 18, 2026

Strongest NEUTRAL IGC Pharma filed its definitive proxy statement for the 2026 Annual Meeting, seeking shareholder approval…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Mar 12 IGC Pharma raised $526,000 through two bridge loans totaling $572,05…
R Apr 20 IGC Pharma raised $514,000 through two unregistered convertible note…
X Jul 31 Short interest jumps 39.2% to 541.7K
X Aug 14 Short interest jumps 41.7% to 767.6K
X Sep 15 Short interest jumps 48.0% to 1.07M

Signal stack

Where each data set points today.

InsidersNO TRADES

No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
InstitutionsMIXED

Q2 2026: 2 added (0 new), 4 trimmed or exited.
AnalystsBULLISH

4 of 5 rate it Buy or better.
Short sellersSTEADY

Short interest −13.2% to 931.5K shares. 1.4 days to cover, ≈0.9% of shares.
TrendDOWNTREND

11% below its 50-day average. New closing low $0.2400 on Oct 21.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
UBS Group AG	NEAR_EXIT	1	—
RENAISSANCE TECHNOLOGIES LLC	TRIM	286,608	$78.0K
NORTHERN TRUST CORP	ADD	170,274	$46.3K
TRUIST FINANCIAL CORP	ADD	48,667	$13.2K
SUSQUEHANNA INTERNATIONAL GROUP, LLP	NEAR_EXIT	28,882	$7.9K
GROUP ONE TRADING LLC	TRIM	2,600	$707.00
RENAISSANCE TECHNOLOGIES LLC	TRIM	483,975	$127.3K
MORGAN STANLEY	ADD	35,118	$9.2K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

5 analysts

Buy 80% rate it Buy or better

Strong Buy1Buy3Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access

Recent actions

Date	Firm	Action	Rating
Aug 26, 2026	Ascendiant Capital MAINTAIN	MAINTAIN	Buy
Jun 8, 2026	Ascendiant Capital MAINTAIN	MAINTAIN	Buy

Insider ledger

Form 4

open-market buys or sells · 12 mo

Date	Insider	Type	Value
Sep 25, 2026	GRIMALDI CLAUDIA PFO	GIFT	150,000 sh
Sep 25, 2026	Mukunda Ram CEO	GIFT	100,000 sh
Jun 30, 2026	GRIMALDI CLAUDIA PFO	AWARD	$553.1K
Jun 30, 2026	Mukunda Ram CEO	AWARD	$601.1K
Apr 1, 2026	Mukunda Ram CEO	EXERCISE	33,332 sh
Apr 1, 2026	GRIMALDI CLAUDIA PFO	EXERCISE	100,000 sh
Apr 1, 2026	PRINS RICHARD K Director	EXERCISE	100,000 sh
Apr 1, 2026	Moran James P Director	EXERCISE	50,000 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data — subscribers only
Next Q	🔒 Fresh data — subscribers only
Current FY	🔒 Fresh data — subscribers only
Next FY	🔒 Fresh data — subscribers only